Vaccination-induced cutaneous pseudolymphoma

Journal of the American Academy of Dermatology

Volumn 52, Issue 4, 2005, Pages 623-629

  Maubec, Eve ^a   Pinquier, Laure ^b   Viguier, Manuelle ^a   Caux, Frédéric ^f   Amsler, Emmanuelle ^d   Aractingi, Sélim ^d   Chafi, Hafid ^g   Janin, Anne ^b   Cayuela, Jean Michel ^c   Dubertret, Louis ^a   Authier, François Jérôme ^e   Bachelez, Hervé ^a,d  

^a Institut de Recherche sur la Peau   (France)

^b Laboratoire d'Anatomie Pathologique   (France)

^c Lab d'Hematologie Molec   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f AVICENNE HOSPITAL   (France)

^g FACULTÉ DES SCIENCES   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BETAMETHASONE DIPROPIONATE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HYDROXYCHLOROQUINE SULFATE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BODY WEIGHT DISORDER; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DEPIGMENTATION; ELECTRON MICROSCOPY; FEMALE; FEVER; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; MYALGIA; ONSET AGE; PATCH TEST; PRIORITY JOURNAL; PRURITUS; PSEUDOLYMPHOMA; SKIN BIOPSY; SKIN DEFECT; SKIN LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; ULTRASTRUCTURE; VACCINATION; VITILIGO; WEIGHT REDUCTION;

EID: 20244376617     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.12.021     Document Type: Article

References (33)

1. P. Ovetchkine Secondary effects of vaccination Arch Pediatr 8 2001 316 320
2. A. Cosnes, M.L. Flechet, and J. Revuz Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization Contact Dermatitis 23 1990 65 67
3. D. Cominos, G. Strutton, and I. Busmanis Granulomas associated with tetanus toxoid immunization Am J Dermatopathol 15 1993 114 117
4. A.L. Bordet, P. Michenet, C. Cohen, F. Arbion, N. Ekindi, and C. Bonneau Post vaccination granuloma due to aluminium Ann Pathol 21 2001 149 152
5. H.A. Fawcett, and N.P. Smith Injection-site granuloma due to aluminum Arch Dermatol 120 1984 1318 1322
6. S.R. Orell Subcutaneous granulomata following inoculation of influenza vaccine Acta Pathol Microbiol Immunol Scand 56 1962 127 134
7. V. Garcia-Patos, R.M. Pujol, A. Alomar, A. Cistero, R. Curell, and M.T. Fernandez-Figueras Persistent subcutaneous nodules in patients hyposensitized with aluminium-containing allergen extracts Arch Dermatol 131 1995 1421 1424
8. J.R. Miliauskas, T. Mukherjee, and B. Dixon Postimmunization (vaccination) injection-site reactions: a report of four cases and review of the literature Am J Surg Pathol 17 1993 516 524
9. M. Erdohazi, and R.L. Newman Aluminium hydroxide granuloma Br Med J 3 1971 621 623
10. D.N. Slater, J.C. Underwood, J.E. Durrant, T. Gray, and I.P. Hopper Aluminium hydroxide granulomas: light and electron microscopic studies and x-ray microanalysis Br J Dermatol 107 1982 103 108
11. W.A. Caro, and E.B. Helwig Cutaneous lymphoid hyperplasia Cancer 24 1969 487 502
12. T. Ploysangam, D.L. Breneman, and D.F. Mutasim Cutaneous pseudolymphomas J Am Acad Dermatol 38 1998 877 895
13. J.U. Rijlaarsdam, and R. Willemze Cutaneous pseudolymphomas: classification and differential diagnosis Semin Dermatol 13 1994 187 196
14. S. Albrecht, S. Hofstadter, H. Arstob, O. Chaban, and L. From Lymphadenosis benigna cutis from Borrelia infection (Borrelia lymphocytoma) J Am Acad Dermatol 24 1991 621 625
15. E. Roo, C. Villegas, and E. Lopez-Bran Postzoster cutaneous pseudolymphoma Arch Dermatol 130 1994 661 663
16. H. Bachelez, F. Hadida, C. Parizot, B. Flageul, M. Kemula, and P. Debré Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in of HIV-1-associated cutaneous pseudolymphoma J Clin Invest 101 1998 2506 2516
17. C.M. Magro, and A.N. Crowson Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia J Am Acad Dermatol 32 1995 419 428
18. W.B. Shelley, and E.D. Shelley Pseudolymphoma at site of clonidine patch Lancet 350 1997 1223 1224
19. G. Blumental, M.R. Okun, and J.A. Ponitch Pseudolymphomatous reaction to tattoos: report of three cases J Am Acad Dermatol 6 1982 485 488
20. R.J. Martsock Post vaccinial lymphadenitis hyperplasia of lymphoid tissue that simulates malignant lymphoma Cancer 21 1968 632 649
21. S. Lanzafame, and G. Micali Cutaneous lymphoid hyperplasia (pseudolymphoma) secondary to vaccination Pathologica 85 1993 555 561
22. H. Bernstein, J. Shupack, and B. Ackerman Cutaneous pseudolymphoma resulting from antigen injections Arch Dermatol 110 1974 756 757
23. J. Soulier, L. Grollet, E. Oksenhendler, J.M. Miclea, P. Cacoub, and A. Baruchel Molecular analysis of clonality in Castleman's disease Blood 86 1995 1131 1138
24. M. Deane, K.P. McCarthy, L.M. Wiedemann, and J.D. Norton An improved method for detection of B-lymphoid clonality by polymerase chain reaction Leukemia 5 1991 726 730
25. H.C. Cook Manual of histological demonstration techniques 1974 Butterworths and Co London
26. A. Watrin, and P. Galle Sites of aluminium accumulation in the bone marrow: study using electron microscopy, ionic microscopy and x-ray microanalysis Biol Cell 57 1986 63 75
27. F. Charlotte, J. Wechsler, P. Joly, M. Bagot, M. Lessana-Leibowitch, and P. Gaulard Non epidermotropic cutaneous pseudolymphomas: a histopathological study of 52 cases Arch Pathol Lab Med 118 1994 56 63
28. D.P. Wirt, C.S. Jolley, C.S. Rangel, C.M. Payne, R.C. Hansen, and P.J. Lynch The immunoarchitecture of cutaneous pseudolymphoma Hum Pathol 16 1985 492 510
29. E. Ralfkiaer, G. Lange Wantzin, D.Y. Mason, H. Stein, and K. Thomsen Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies Br J Dermatol 111 1984 634 635
30. R.K. Gherardi, M. Coquet, and P. Chérin Macrophagic myofasciitis: an emerging entity Lancet 352 1998 347 352
31. R.K. Gherardi, M. Coquet, P. Chérin, L. Belec, P. Moretto, and P.A. Dreyfus Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle Brain 124 2001 1821 1831
32. J.M. Brewer, M. Conacher, C.A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of Il-4 and Il-13-mediated signalling J Immunol 163 1999 6448 6454
33. M. Ulanova, A. Tarkowski, M. Hahn Zoric, and L.A. Hanson The common vaccine adjuvant aluminium hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism Infect Immun 69 2001 1151 1159